M
Matthew Bell Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
faculty
9 h-index
17 pubs
801 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Matthew Bell's research focuses on the role of mononuclear myeloid cells in inflammatory conditions, particularly inflammatory bowel disease (IBD) and Crohn's disease. He investigates therapeutic strategies targeting these cells to modulate inflammatory mediators and pathways. His work includes the study of BET protein inhibitors and their effects on specific inflammatory pathways, as well as the exploration of carboxylesterase-1 assisted targeting of HDAC inhibitors.
His recent publications also touch upon the epigenetic regulation of dendritic cell function and potential applications in immunotherapy. Bell has contributed to studies on specific treatment syndromes, including Trofinetide-Induced Enterocolitis Syndrome in children with Rett Syndrome. His research network includes collaborators from the University of Arkansas for Medical Sciences, such as Stephen G. Jones and John Alberty.
Metrics
- h-index: 9
- Publications: 17
- Citations: 801
Selected Publications
-
Trofinetide-Induced Enterocolitis Syndrome in a Child with Rett Syndrome (2025)
Collaboration Network
Top Collaborators
Wouter J. de Jonge
University of Bonn (DE)
4 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Ishtu Hageman
Amsterdam University Medical Centers (NL)
3 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Jan Verhoeff
Amsterdam University Medical Centers (NL)
3 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Manon E. Wildenberg
University of Amsterdam (NL)
3 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Rab K. Prinjha
GlaxoSmithKline (United Kingdom) (GB)
3 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential
Rebecca C. Furze
Age UK (GB)
3 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Ahmed M I Elfiky
University of Amsterdam (NL)
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
Mohammed Ghiboub
GlaxoSmithKline (United Kingdom) (GB)
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential
Andrew Y. F. Li Yim
University of Amsterdam (NL)
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
Juan J. García‐Vallejo
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Inmaculada Rioja
Age UK (GB)
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
Palwinder K. Mander
Age UK (GB)
2 shared publications
- Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
Marte Becker
Amsterdam University Medical Centers (NL)
2 shared publications
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
V Joustra
Amsterdam University Medical Centers (NL)
2 shared publications
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Geert D’Haens
Amsterdam University Medical Centers (NL)
2 shared publications
- A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
- Mo1130: CHARACTERISING MONONUCLEAR MYELOID CELLS AND PROFILING THE EFFECTS OF BET INHIBITORS IN BIOLOGICS NON-RESPONDING CROHN'S DISEASE PATIENTS
Similar Researchers
Based on overlapping research topics
Christopher M. Johnson
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Inflammatory Bowel Disease
Pharmacological Effects and Toxicity Studies
AbdelHai Hammo
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Inflammatory Bowel Disease
Pharmacological Effects and Toxicity Studies
John Alberty
University of Arkansas for Medical Sciences
Inflammatory Bowel Disease
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
Michael Bauer
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Pharmacological Effects and Toxicity Studies
Epigenetics and DNA Methylation
Kamylla Teixeira Santos
University of Arkansas at Fayetteville
Immune Response and Inflammation
Inflammatory Bowel Disease
Metabolism and Genetic Disorders
Travis Ayers
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Inflammatory Bowel Disease
Pharmacological Effects and Toxicity Studies